In presence of HCC + SH, TLR-4 was statistically reduced at gene and protein level also with respect the sole HCC treatment, confirming the actual efficacy of this formulation suitable to attenuate damages due to PS. This evidence concerns the gene TLR4 and hepatocellular carcinoma.